Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2023International Journal of Molecular SciencesOpen Access

PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets

View Full Paper
Ask AI
Bookmark
Share

Key result

Targeting PDE4 enzymes presents intricate therapeutic challenges for cardiovascular disease despite key functional roles.

Why the study?

PDE4 enzymes fine-tune cAMP signaling to influence cardiovascular function and disease, presenting intricate challenges for targeting them as a therapeutic strategy.

Design

Review

Authors

LPLídia Puertas-UmbertJAJudith AlonsoLHLeif Hove‐Madsen

Discussion

Loading...

Member takes

Overview

Intricate challenges in PDE4 targeting advise clinical caution for cardiovascular disease; leaves open isoform-selective strategies for targeted research.

PICO

P
Population
Cardiovascular diseases
I
Intervention / Comparator
PDE4 enzyme targeting

PDE4 enzymes are critical regulators of cAMP signaling in cardiovascular tissues and represent a potential, albeit challenging, therapeutic target for cardiovascular diseases.

Cite This Study

Puertas-Umbert et al. (2023) conducted a review in Cardiovascular diseases. PDE4 enzyme targeting was evaluated. Targeting PDE4 enzymes presents intricate challenges as a therapeutic strategy for managing cardiovascular diseases, despite their key role in cardiac and vascular function.

synapsesocial.com/papers/6a1c1fc6ea84844e355f7ac3https://doi.org/10.3390/ijms242317017
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1β-Adrenergic Receptor Blockers Restore Cardiac Calcium Release Channel (Ryanodine Receptor) Structure and Function in Heart Failure2001 · 181 citations
  2. 2Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure1991 · 2,240 citations
  3. 3Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation2022 · 66 citations
  4. 4Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF62020 · 26 citations
  5. 5Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease)2018 · 146 citations